Magnesium%25252525252525252525252525252525252525252525252520sulfate

# Magnesium Sulfate ## Overview Magnesium sulfate is an essential mineral and electrolyte. It is available for intravenous (IV) and intramuscular (IM) administration, as well as oral and topical formulations. ## Primary Indications * **Hypomagnesemia:** Treatment of documented or suspected magnesium deficiency. * **Eclampsia/Preeclampsia:** Prophylaxis and treatment of seizures associated with severe preeclampsia and eclampsia. * **Torsades de Pointes:** Treatment of polymorphic ventricular tachycardia (Torsades de Pointes). * **Status Epilepticus:** Adjunctive therapy for refractory status epilepticus. * **Bronchodilator:** Adjunctive therapy in severe, refractory acute asthma exacerbations. * **Constipation:** Oral magnesium citrate or oxide used as a laxative. ## Adult Dosing * **Hypomagnesemia:** * **Acute Symptomatic:** 4-6 grams IV infused over 5-60 minutes, followed by 1-2 grams per hour IV infusion. Dosing varies based on severity. * **Chronic Repletion:** 1 gram IM every 6 hours for 4 doses, or 2-6 grams IV per day. * *Maximum IV infusion rate typically 1-2 grams/hour.* * **Eclampsia/Preeclampsia (ACLS/ACOG Guidelines):** * **Loading Dose:** 4-6 grams IV infused over 5-20 minutes. * **Maintenance Infusion:** 1-2 grams per hour IV. * **IM alternative:** 5 grams IM in each buttock initially, followed by 5 grams IM in alternating buttocks every 4 hours. * **Torsades de Pointes:** 1-2 grams IV in 50-100 mL D5W infused over 5-10 minutes. May repeat if needed, followed by 0.5-1 gram/hour infusion. * **Status Epilepticus (Refractory):** 1-2 grams IV over 5 minutes, may repeat every 15-30 minutes up to a cumulative dose of 4-6 grams. * **Asthma Exacerbation (Adjunctive):** 1-2 grams IV infused over 15-30 minutes. * **Laxative (Oral):** Magnesium citrate (e.g., 10 oz solution) or magnesium oxide (e.g., 2-4 grams). ## Pediatric Dosing * **Hypomagnesemia:** Dosing is highly variable and often based on weight and calculated deficit. A common guideline for severe depletion is 25-50 mg/kg IV over a period of 1-4 hours, not to exceed adult doses. Maintenance doses also vary. * **Eclampsia:** Dosing follows adult guidelines but may be adjusted for weight. * **Torsades de Pointes:** Dosing similar to adults, 25-100 mg/kg IV (max 2 grams) over 10-20 minutes. * **Asthma Exacerbation (Adjunctive):** 25-40 mg/kg IV (max 2 grams) infused over 15-30 minutes for severe cases. *Specific pediatric dosing should be guided by institutional protocols and specialist consultation.* ## Dose Adjustments * **Renal Impairment:** Magnesium is renally eliminated. Use with extreme caution in patients with impaired renal function. Reduce dose and monitor serum magnesium levels closely. ## Contraindications * Hypersensitivity to magnesium sulfate. * Hypermagnesemia. * Heart block or myocardial damage. * Renal failure (relative contraindication, necessitates dose reduction and caution). ## Adverse Effects * **Cardiovascular:** Hypotension, flushing, bradycardia, ECG changes, cardiac arrest. * **Neuromuscular:** Lethargy, decreased deep tendon reflexes, muscle weakness, respiratory depression, apnea, coma. * **Gastrointestinal:** Diarrhea (oral forms), nausea, vomiting. * **Other:** Hyperthermia, sweating. ## Key Drug Interactions * **Neuromuscular Blocking Agents:** Magnesium can potentiate neuromuscular blockade, leading to prolonged respiratory depression. * **Calcium:** IV calcium may be used as an antidote for severe magnesium toxicity. * **Tetracyclines and Fluoroquinolones:** Magnesium can form complexes with these antibiotics, reducing their absorption. Separate administration by at least 2 hours. * **Digoxin:** Risk of digoxin toxicity if hypomagnesemia is corrected too rapidly. * **Nifedipine:** Concomitant use has been associated with profound hypotension. ## Monitoring * **Serum Magnesium Levels:** Monitor regularly, especially during IV infusions and in patients with renal impairment. Target levels vary by indication. For hypomagnesemia, aim for 2.5-4.5 mg/dL. For eclampsia, therapeutic range is typically 4.0-8.0 mg/dL. * **Renal Function:** Assess baseline and monitor serum creatinine. * **Deep Tendon Reflexes:** Assess for loss of reflexes, which can indicate magnesium toxicity. * **Respiratory Rate:** Monitor for signs of respiratory depression. * **Urine Output:** Monitor for adequate renal excretion. * **ECG:** Monitor for cardiac effects, especially in patients receiving high doses or with known cardiac issues. ## Clinical Pearls * Magnesium sulfate is a CNS depressant and smooth muscle relaxant. * Always dilute IV magnesium sulfate before administration. Rapid IV infusion can cause hypotension and cardiac arrhythmias. * The antidote for severe magnesium toxicity is intravenous calcium (gluconate or chloride). * In patients with renal impairment, prolonged infusions or higher doses can lead to accumulating, potentially toxic levels. * For suspected magnesium toxicity, assess for absent deep tendon reflexes, respiratory depression, and altered mental status. *** **Disclaimer:** This information is intended for healthcare professionals. This is not exhaustive and does not replace the need to consult the official prescribing information and relevant clinical guidelines before prescribing or administering magnesium sulfate. Dosage and administration may vary based on specific patient factors and institutional protocols.